The MYBL2–CCL2 axis promotes tumor progression and resistance to anti-PD-1 therapy in ovarian cancer by inducing immunosuppressive macrophages

Baoyue Pan(Sun Yat-sen University), Min Zheng(Second Affiliated Hospital of Zhejiang University)

Cancer Cell International

October 21, 2023

10.1186/s12935-023-03079-2

Cited by 27

Related Papers

SPAG5 upregulation predicts poor prognosis in cervical cancer patients and alters sensitivity to taxol treatment via the mTOR signaling pathway

|Cell Death and Disease|2014|90

Role of VEGF Receptors in Normal and Psoriatic Human Keratinocytes: Evidence from Irradiation with Different UV Sources

|PLoS ONE|2013|22